These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9681205)

  • 1. Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in rats.
    Zaccheo T; Giudici D; Panzeri A; di Salle E
    Chemotherapy; 1998; 44(4):284-92. PubMed ID: 9681205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with the 5 alpha-reductase inhibitor PNU 157706 and the antiandrogen flutamide on the Dunning R3327 prostatic carcinoma in rats.
    Zaccheo T; Giudici D; di Salle E
    Endocr Relat Cancer; 1999 Sep; 6(3):429-35. PubMed ID: 10516856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of Dunning R3327 rat prostatic tumor with the 5alpha-reductase inhibitor PNU 157706 and the antiandrogen bicalutamide.
    Zaccheo T; Giudici D; Panzeri A; di Salle E
    Cancer Chemother Pharmacol; 2000; 45(1):31-7. PubMed ID: 10647498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the dual 5alpha-reductase inhibitor PNU 157706 on the growth of dunning R3327 prostatic carcinoma in the rat.
    Zaccheo T; Giudici D; di Salle E
    J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):193-8. PubMed ID: 9605414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.
    Zaccheo T; Giudici D; di Salle E
    Prostate; 1997 Feb; 30(2):85-91. PubMed ID: 9051146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat.
    di Salle E; Giudici D; Biagini L; Cominato C; Briatico G; Panzeri A
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):381-5. PubMed ID: 7626485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327.
    Brooks JR; Berman C; Nguyen H; Prahalada S; Primka RL; Rasmusson GH; Slater EE
    Prostate; 1991; 18(3):215-27. PubMed ID: 1850515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.
    Brooks JR; Baptista EM; Berman C; Ham EA; Hichens M; Johnston DB; Primka RL; Rasmusson GH; Reynolds GF; Schmitt SM; Arth GE
    Endocrinology; 1981 Sep; 109(3):830-6. PubMed ID: 7262023
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential androgen blockade: a biological study in the inhibition of prostatic growth.
    Fleshner NE; Trachtenberg J
    J Urol; 1992 Dec; 148(6):1928-31. PubMed ID: 1331549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats.
    Imada S; Akaza H; Ami Y; Koiso K; Ideyama Y; Takenaka T
    Eur Urol; 1997; 31(3):360-4. PubMed ID: 9129932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor.
    di Salle E; Giudici D; Radice A; Zaccheo T; Ornati G; Nesi M; Panzeri A; Délos S; Martin PM
    J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):179-86. PubMed ID: 9605412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA.
    Martel C; Trudel C; Couet J; Labrie C; Bélanger A; Labrie F
    Mol Cell Endocrinol; 1993 Feb; 91(1-2):43-9. PubMed ID: 8472853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early exposure of flutamide on subsequent growth of transplantable rat prostatic tumor (dunning R-3327).
    Lee SZ; Sato N; Suzuki H; Watabe Y; Masai M; Shimazaki J
    Prostate; 1994 Apr; 24(4):197-203. PubMed ID: 8146068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination effect of flutamide and leuprorelin acetate on growth of Dunning R3327-H prostatic adenocarcinoma in rats].
    Tomura A; Kuroiwa S; Okada M; Abe F
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):563-9. PubMed ID: 9530363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of flutamide and finasteride on rat testicular descent.
    Spencer JR; Torrado T; Sanchez RS; Vaughan ED; Imperato-McGinley J
    Endocrinology; 1991 Aug; 129(2):741-8. PubMed ID: 1677329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of an antiandrogen and a 5 alpha-reductase inhibitor: a further step towards total androgen blockade?
    Labrie C; Trudel C; Li S; Martel C; Couêt J; Labrie F
    Endocrinology; 1991 Jul; 129(1):566-8. PubMed ID: 2055205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyproterone acetate in comparison to flutamide on the ventral prostate of adult male castrated Copenhagen-Fisher rats and on Dunning R-3327 H tumors.
    Donn F; Becker H; Klosterhalfen H; Klein H
    Andrologia; 1989; 21(5):462-7. PubMed ID: 2530921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
    Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A
    Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Win 49,596, a novel steroidal androgen receptor antagonist, in animal models of prostate cancer.
    Juniewicz PE; Fetrow N; Marinelli J; Wolf M; Young E; Lamb J; Isaacs JT
    Prostate; 1991; 18(2):105-15. PubMed ID: 2006117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.